Residency · Buffalo, NY
Sponsored by University at Buffalo School of Medicine
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
Journal of diabetes science and technology · 2023 · 237 citations · Mohammed Al-Sofiani
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022 · 391 citations · Zakariya Kashour
Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis.
Gastroenterology · 2025 · 62 citations · Tsu Wang
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology (Baltimore, Md.) · 2022 · 215 citations · Abdul Naqash
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysis.
Annals of internal medicine · 2026 · 22 citations · Tsu Wang
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer.
Nature reviews. Clinical oncology · 2024 · 119 citations ·
Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
The New England journal of medicine · 2023 · 144 citations · Abdul Naqash
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies.
The Lancet. Oncology · 2025 · 44 citations · Abdul Naqash